| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 07/27/1989 | WO1989006692A1 Method of treating tumor cells by inhibiting growth factor receptor function |
| 07/27/1989 | WO1989006646A1 2-amino acetamide derivatives |
| 07/27/1989 | WO1989006543A1 Htlv-i peptide antigen and assay |
| 07/27/1989 | WO1989005650A3 Chemical process |
| 07/27/1989 | DE3902157A1 Amphiregulin, verfahren zu dessen herstellung und pharmazeutische mittel Amphiregulin, process for its preparation and pharmaceutical compositions |
| 07/27/1989 | DE3843054A1 Neue kristallform von cyclosporin, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese kristallform sowie ihre anwendung New crystal form of cyclosporin, processes for their preparation, pharmaceutical compositions containing said crystalline form as well as their use |
| 07/26/1989 | EP0325224A2 Methods of producing secreted receptor analogs and biologically active peptide dimers. |
| 07/26/1989 | EP0325160A2 Amino-acid glycerides, process for their preparation, medicaments containing them and their use |
| 07/26/1989 | EP0325044A2 Pharmacologically active cyclic peptide |
| 07/26/1989 | EP0324789A1 Methods of regulating metabolic stability of proteins |
| 07/25/1989 | US4852017 Determination of peptide sequences |
| 07/25/1989 | US4851563 Method for the removal of the formyl group from an ester of an N-formyl peptide or N-formyl aminoacid |
| 07/25/1989 | US4851528 Anthraquinone derivatives |
| 07/25/1989 | US4851388 Heptanoyl-glu-asp-ala-amino acid immunostimulants |
| 07/25/1989 | US4851345 Absorption during fibrin chromatography, then non-absorption in lysine chromatography |
| 07/25/1989 | US4851341 Forming protein-monoclonal antibody complex, isolation, dissociating |
| 07/19/1989 | EP0324648A2 Recombinant eimeria tenella vaccines |
| 07/19/1989 | EP0324625A1 Antigen antibody conjugate |
| 07/19/1989 | EP0324556A2 Method to improve mRNA translation and use thereof for production of platelet factor-4 |
| 07/19/1989 | EP0324270A1 Biologically active peptides |
| 07/19/1989 | CN1034021A Production of immunoproximity catalysts |
| 07/18/1989 | US4849511 Technetium chelates to be used for determining the renal function |
| 07/18/1989 | CA1257746A1 Homocyclic derivatives |
| 07/13/1989 | WO1989006286A2 Probes for and methods of diagnosis for muscular dystrophy |
| 07/13/1989 | WO1989006241A1 Sorbin and peptide derivatives which increase aborption by the mucous membranes |
| 07/13/1989 | WO1989006239A1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 07/12/1989 | EP0323948A2 Continuous isoelectric separation |
| 07/12/1989 | EP0323806A1 Novel chimeric antibodies |
| 07/12/1989 | EP0323740A2 Linear analogs of atrial natriuretic peptides |
| 07/11/1989 | US4847363 Electrophoresis |
| 07/11/1989 | US4847362 Method for purifying antihemophilic factor |
| 07/11/1989 | US4847159 Substrates coated with organo-silanes that are sterically-protected |
| 07/11/1989 | CA1257211A1 Process for obtaining a fviii/vwf complex having therapeutic effects and product thus prepared |
| 07/06/1989 | DE3842378A1 Acid-labile anchoring groups for the synthesis of peptide amides by means of a solid-phase method |
| 07/05/1989 | EP0323027A2 Monoclonal antibody purification process |
| 07/05/1989 | EP0322870A2 Synthetic plasmid, transformant, feline interferon gene and method for producing feline interferon |
| 07/04/1989 | US4845194 Adsorption on styrene-divinylbenzene resin |
| 07/04/1989 | US4845032 Dissolving in guanidine hydrochloride, precipitation, chromatography |
| 07/04/1989 | CA1256796A1 Cytotoxic conjugates which can be used in therapy and process for their preparation |
| 06/29/1989 | WO1989005857A1 A METHOD OF SIMULTANEOUSLY PRODUCING A LARGE NUMBER OF Leu17-VIP-ANALOGS AND NEW Leu17-VIP-ANALOGS |
| 06/29/1989 | WO1989005824A1 Site-specific homogeneous modification of polypeptides to facilitate covalent linkages to a hydrophilic moiety |
| 06/29/1989 | WO1989005822A1 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
| 06/29/1989 | WO1989005818A1 Purine derivatives having pharmacological action |
| 06/29/1989 | WO1989005816A1 Cellular toxic conjugates |
| 06/29/1989 | WO1989005654A1 Linear analogs of atrial natriuretic peptides |
| 06/29/1989 | WO1989005650A2 Chemical process |
| 06/28/1989 | EP0322348A2 Acidically non-stable anchoring groups for solid-phase peptide amide synthesis |
| 06/28/1989 | EP0322262A1 Basic protein phospholipase A2 of an Elapide snake venom, amino acid sequence thereof, derivatives and fragments thereof, process for obtaining them, therapeutic compositions and diagnostic agents containing them |
| 06/28/1989 | EP0322226A2 Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 06/28/1989 | EP0322184A2 N-(2-Alkyl-3-mercapto-1,5-di-oxoalkyl)glycinamide derivatives and their use as collagenase inhibitors |
| 06/28/1989 | EP0322146A2 Antibody and antigen |
| 06/28/1989 | EP0321940A2 An improved method for the preparation of natural human growth hormone in pure form |
| 06/28/1989 | EP0321835A2 Gel filteration of factor VIII |
| 06/28/1989 | EP0321722A2 Process for obtaining dipeptides |
| 06/28/1989 | EP0321696A2 Novel hydrogenated derivatives of antibiotic A/16686 |
| 06/28/1989 | EP0321606A1 Cellular amphipatic proteins in aggregated forms, and procedure for the production and purification of these proteins |
| 06/28/1989 | EP0321526A1 Cloning and expression of human tissue factor |
| 06/27/1989 | US4843147 Anhydrous enhanced coupling of proteins |
| 06/27/1989 | US4843019 Monoclonal antibodies |
| 06/22/1989 | DE3741469A1 Process for the fractionation of protein hydrolysates |
| 06/21/1989 | EP0320967A2 ANF derivatives with novel bridging |
| 06/21/1989 | EP0320849A1 Apatite packing for liquid chromatography and process for producing the same |
| 06/21/1989 | EP0320840A2 Peptides, method for their preparation, antibodies to it, and their use in blocking the PAI-1 activity of human blood |
| 06/21/1989 | EP0320785A2 Peptides influencing the activity of the hypophysis of mammalians |
| 06/20/1989 | US4841025 Antibody preparations |
| 06/20/1989 | US4840935 Peptide amino-alcohol derivatives containing a tetrasubstituted carbon atom, inhibiting renin and acid proteases, process for obtention and therapeutical use |
| 06/20/1989 | US4840894 Using protein antibody complex |
| 06/20/1989 | US4840785 Polypeptide |
| 06/20/1989 | CA1256250A1 Covalently-modified neutral bacterial poly- saccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates |
| 06/20/1989 | CA1256042A1 Process for the purification of hbsag |
| 06/20/1989 | CA1256027A1 Fibrinophilic urokinase complex and method for production thereof |
| 06/20/1989 | CA1256024A1 Method of immunological dosage of monoamines |
| 06/15/1989 | WO1989005353A1 Common acute lymphoblastic leukemia antigen |
| 06/15/1989 | WO1989005305A1 Polymers and polymer-peptide conjugates |
| 06/15/1989 | WO1989005156A1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 06/15/1989 | WO1989005150A1 Conformationally stabilized cell adhesion peptides |
| 06/14/1989 | EP0320267A2 Glycoprotein growth modulation materials |
| 06/14/1989 | EP0320205A2 Renin inhibiting dipeptides, their preparation and compositions containing them |
| 06/14/1989 | EP0320204A2 Renin inhibiting dipeptides, their preparation and compositions containing them |
| 06/14/1989 | EP0319664A1 Soluble, iron-containing polypeptide derivatives, their preparation and pharmaceutical uses |
| 06/13/1989 | CA1255850A1 Peptides with disulfide bridges and method |
| 06/13/1989 | CA1255849A1 Method for separating polypeptides |
| 06/13/1989 | CA1255588A1 Chemically modified lymphokine and production thereof |
| 06/13/1989 | CA1255586A1 Method of determining mimotopes |
| 06/07/1989 | EP0319315A2 The von Willebrand factor binding domain of factor VIII |
| 06/07/1989 | EP0319253A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 06/07/1989 | EP0319052A2 Mutant acidic fibroblast growth factor |
| 06/07/1989 | EP0319012A2 Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension |
| 06/07/1989 | CN1033289A Preparation of monostrepurokinase |
| 06/06/1989 | US4837332 Process for blocking amino acids with the tertiary-alkoxycarbonyl group |
| 06/06/1989 | US4837303 Novel somatostatin derivatives |
| 06/06/1989 | US4837165 Method for sequencing of peptides by carboxyl terminus degradation |
| 06/06/1989 | CA1255220A1 Highly solubilized protein and production thereof |
| 06/01/1989 | WO1989004872A1 Immunoreactive heterochain antibodies |
| 06/01/1989 | WO1989004836A1 Neutrophil-activating factor |
| 06/01/1989 | WO1989004834A1 Immunoglobulin e competitor |
| 06/01/1989 | WO1989004608A1 Process for extracting pure fractions of lactoperoxidase and lactoferrin from milk serum |
| 06/01/1989 | WO1989003396A3 Antibodies to natural killer cell and non-specific cytotoxic cell receptor |
| 05/31/1989 | EP0318451A2 DNA clone of human tissue factor inhibitor |
| 05/31/1989 | EP0318338A1 Process for the preparation of peptide synthons |